{"id":34932,"date":"2015-04-22T10:35:01","date_gmt":"2015-04-22T14:35:01","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=34932"},"modified":"2015-04-22T10:35:01","modified_gmt":"2015-04-22T14:35:01","slug":"biocept-inc-nasdaqbioc-long-term-support-around-2-levels","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/biocept-inc-nasdaqbioc-long-term-support-around-2-levels-34932","title":{"rendered":"Biocept Inc (NASDAQ:BIOC) \u2013 Long Term Support Around $2 Levels"},"content":{"rendered":"<p style=\"text-align: justify;\"><strong>Biocept Inc (NASDAQ:BIOC)<\/strong> opened with a big gap up in the last trading session but the latter hours saw the stock losing all the morning gain and ending the session with a loss of 6.85%. The volume surged to 21 million against the daily average volume of 2.5 million only. Just in the previous trading session, the stock had rallied by 26.81% but the profit booking dragged it lower. The stock continues to trade in the middle of the huge 52-week range, as evident from the 52-week high of $7.72, 59.46% away and the 52-week low of $1.09, with the current trading price still 187% away from it.<\/p>\n<p style=\"text-align: justify;\">Biocept Inc (NASDAQ:BIOC) has collaborated with the University of California, San Diego Moores Cancer Center. Blood samples for non-small cell lung cancer patients will be taken and tested with the company\u2019s OncoCEE \u2122 LU platform and CEE Selector \u2122 technology for determination of the clinical utility of detecting biomarkers present in CTCs and ctDNA. For detecting and monitoring cancer mutations, a highly quantitative and sensitive blood based method is offered by Biocept Inc (NASDAQ:BIOC).<\/p>\n<p style=\"text-align: justify;\"><a href=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2015\/04\/3.jpg\"><img fetchpriority=\"high\" decoding=\"async\" class=\" size-full wp-image-34933 aligncenter\" src=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2015\/04\/3.jpg\" alt=\"3\" width=\"640\" height=\"460\" srcset=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2015\/04\/3.jpg 640w, https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2015\/04\/3-300x216.jpg 300w, https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2015\/04\/3-77x55.jpg 77w\" sizes=\"(max-width: 640px) 100vw, 640px\" \/><\/a><\/p>\n<p style=\"text-align: justify;\">Technically, the stock is trading in a broad range of $2.00-$4.50 for the last 6-8 months. Attempts to break out of the range on both directions have failed so far. The level of $2 has been long acted as an excellent support and though the bears managed to break it once, they failed to keep the price below that level for long.<\/p>\n<p style=\"text-align: justify;\">The long term picture shows the price getting resisted twice from the $10 levels in the last decade and the price bouncing from $2 levels the same number of times. So a very aggressive investor may try some high risk bottom fishing in the area of $1-$2 for a possible spectacular return in the coming months.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Biocept Inc (NASDAQ:BIOC) opened with a big gap up in the last trading session but the latter hours saw the stock losing all the morning [&hellip;]<\/p>\n","protected":false},"author":10,"featured_media":34934,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[7062,7063],"stock_ticker":[],"class_list":["post-34932","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-biocept-inc-nasdaqbioc","tag-nasdaqbioc","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Biocept Inc (NASDAQ:BIOC) \u2013 Long Term Support Around $2 Levels - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/biocept-inc-nasdaqbioc-long-term-support-around-2-levels-34932\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Biocept Inc (NASDAQ:BIOC) \u2013 Long Term Support Around $2 Levels - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Biocept Inc (NASDAQ:BIOC) opened with a big gap up in the last trading session but the latter hours saw the stock losing all the morning [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/biocept-inc-nasdaqbioc-long-term-support-around-2-levels-34932\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2015-04-22T14:35:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2015\/04\/BIO.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"352\" \/>\n\t<meta property=\"og:image:height\" content=\"143\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Alan Masterson\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Alan Masterson\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/biocept-inc-nasdaqbioc-long-term-support-around-2-levels-34932#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/biocept-inc-nasdaqbioc-long-term-support-around-2-levels-34932\"},\"author\":{\"name\":\"Alan Masterson\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e2af522c6015a6a581684f88e4c33c90\"},\"headline\":\"Biocept Inc (NASDAQ:BIOC) \u2013 Long Term Support Around $2 Levels\",\"datePublished\":\"2015-04-22T14:35:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/biocept-inc-nasdaqbioc-long-term-support-around-2-levels-34932\"},\"wordCount\":300,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/biocept-inc-nasdaqbioc-long-term-support-around-2-levels-34932#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2015\/04\/BIO.jpeg\",\"keywords\":[\"Biocept Inc (NASDAQ:BIOC)\",\"NASDAQ:BIOC\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/biocept-inc-nasdaqbioc-long-term-support-around-2-levels-34932#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/biocept-inc-nasdaqbioc-long-term-support-around-2-levels-34932\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/biocept-inc-nasdaqbioc-long-term-support-around-2-levels-34932\",\"name\":\"Biocept Inc (NASDAQ:BIOC) \u2013 Long Term Support Around $2 Levels - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/biocept-inc-nasdaqbioc-long-term-support-around-2-levels-34932#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/biocept-inc-nasdaqbioc-long-term-support-around-2-levels-34932#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2015\/04\/BIO.jpeg\",\"datePublished\":\"2015-04-22T14:35:01+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/biocept-inc-nasdaqbioc-long-term-support-around-2-levels-34932#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/biocept-inc-nasdaqbioc-long-term-support-around-2-levels-34932\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/biocept-inc-nasdaqbioc-long-term-support-around-2-levels-34932#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2015\/04\/BIO.jpeg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2015\/04\/BIO.jpeg\",\"width\":352,\"height\":143},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/biocept-inc-nasdaqbioc-long-term-support-around-2-levels-34932#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Biocept Inc (NASDAQ:BIOC) \u2013 Long Term Support Around $2 Levels\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e2af522c6015a6a581684f88e4c33c90\",\"name\":\"Alan Masterson\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/f09370963119b5d583d3dec68718fdaffc52a80c920398e0d1387fee0a33129e?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/f09370963119b5d583d3dec68718fdaffc52a80c920398e0d1387fee0a33129e?s=96&d=mm&r=g\",\"caption\":\"Alan Masterson\"},\"description\":\"Alan has over 25 years of trading experience in the U.S. equity markets. He began his career in finance working on a program trading desk specializing in over-the-counter stocks. His career progressed from that point to his current position as senior trader on an institutional trading desk. In the evenings, Alan teaches economics at a local community college. He has contributed articles to various publications over the last six years, including feature articles for an economics magazine and various financial blogs. You may contact Alan via his email (alanmasterson@cablemanpro.com) or his Google+ page (https:\/\/plus.google.com\/103338576216002376250).\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/alan-masterson\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Biocept Inc (NASDAQ:BIOC) \u2013 Long Term Support Around $2 Levels - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/biocept-inc-nasdaqbioc-long-term-support-around-2-levels-34932","og_locale":"en_US","og_type":"article","og_title":"Biocept Inc (NASDAQ:BIOC) \u2013 Long Term Support Around $2 Levels - Wall Street PR","og_description":"Biocept Inc (NASDAQ:BIOC) opened with a big gap up in the last trading session but the latter hours saw the stock losing all the morning [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/biocept-inc-nasdaqbioc-long-term-support-around-2-levels-34932","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2015-04-22T14:35:01+00:00","og_image":[{"width":352,"height":143,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2015\/04\/BIO.jpeg","type":"image\/jpeg"}],"author":"Alan Masterson","twitter_misc":{"Written by":"Alan Masterson","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/biocept-inc-nasdaqbioc-long-term-support-around-2-levels-34932#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/biocept-inc-nasdaqbioc-long-term-support-around-2-levels-34932"},"author":{"name":"Alan Masterson","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e2af522c6015a6a581684f88e4c33c90"},"headline":"Biocept Inc (NASDAQ:BIOC) \u2013 Long Term Support Around $2 Levels","datePublished":"2015-04-22T14:35:01+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/biocept-inc-nasdaqbioc-long-term-support-around-2-levels-34932"},"wordCount":300,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/biocept-inc-nasdaqbioc-long-term-support-around-2-levels-34932#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2015\/04\/BIO.jpeg","keywords":["Biocept Inc (NASDAQ:BIOC)","NASDAQ:BIOC"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/biocept-inc-nasdaqbioc-long-term-support-around-2-levels-34932#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/biocept-inc-nasdaqbioc-long-term-support-around-2-levels-34932","url":"https:\/\/cablemanpro.com\/wallstreetpr\/biocept-inc-nasdaqbioc-long-term-support-around-2-levels-34932","name":"Biocept Inc (NASDAQ:BIOC) \u2013 Long Term Support Around $2 Levels - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/biocept-inc-nasdaqbioc-long-term-support-around-2-levels-34932#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/biocept-inc-nasdaqbioc-long-term-support-around-2-levels-34932#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2015\/04\/BIO.jpeg","datePublished":"2015-04-22T14:35:01+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/biocept-inc-nasdaqbioc-long-term-support-around-2-levels-34932#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/biocept-inc-nasdaqbioc-long-term-support-around-2-levels-34932"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/biocept-inc-nasdaqbioc-long-term-support-around-2-levels-34932#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2015\/04\/BIO.jpeg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2015\/04\/BIO.jpeg","width":352,"height":143},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/biocept-inc-nasdaqbioc-long-term-support-around-2-levels-34932#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Biocept Inc (NASDAQ:BIOC) \u2013 Long Term Support Around $2 Levels"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e2af522c6015a6a581684f88e4c33c90","name":"Alan Masterson","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/f09370963119b5d583d3dec68718fdaffc52a80c920398e0d1387fee0a33129e?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f09370963119b5d583d3dec68718fdaffc52a80c920398e0d1387fee0a33129e?s=96&d=mm&r=g","caption":"Alan Masterson"},"description":"Alan has over 25 years of trading experience in the U.S. equity markets. He began his career in finance working on a program trading desk specializing in over-the-counter stocks. His career progressed from that point to his current position as senior trader on an institutional trading desk. In the evenings, Alan teaches economics at a local community college. He has contributed articles to various publications over the last six years, including feature articles for an economics magazine and various financial blogs. You may contact Alan via his email (alanmasterson@cablemanpro.com) or his Google+ page (https:\/\/plus.google.com\/103338576216002376250).","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/alan-masterson"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/34932","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=34932"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/34932\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/34934"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=34932"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=34932"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=34932"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=34932"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}